PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility

30 сен 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries

21 сен 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021

15 сен 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

08 сен 2021 07:00:04 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021

10 авг 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference

04 авг 2021 07:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

03 авг 2021 07:00:03 Источник Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process

02 авг 2021 07:00:01 Источник Nasdaq GlobeNewswire

New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty

29 июл 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021

20 июл 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

13 июл 2021 07:00:03 Источник Nasdaq GlobeNewswire

Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America

22 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

08 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block

26 май 2021 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference

25 май 2021 07:00:03 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL

18 май 2021 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference

12 май 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021

11 май 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update

04 май 2021 07:00:01 Источник Nasdaq GlobeNewswire

Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021

21 апр 2021 06:30:00 Источник Nasdaq GlobeNewswire